Status:
COMPLETED
Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Lead Sponsor:
Purdue Pharma LP
Conditions:
Low Back Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The primary objective is to assess the efficacy of oxycodone/naloxone (OXN) for the management of opioid-induced constipation (OIC) compared to oxycodone controlled-release tablets (OXY) in subjects w...
Eligibility Criteria
Inclusion
- Inclusion Criteria include:
- Male and female subjects ≥ 18 years of age with moderate to severe, chronic low back pain (lasting at least several hours daily) as their predominant pain condition for at least 3 months prior to screening period;
- The low back pain must be related to nonmalignant and nonneuropathic conditions and may be with or without radiation;
- Subjects must have a self-reported history of opioid induced constipation (OIC).
- Exclusion Criteria include:
- Subjects with rheumatoid arthritis or other inflammatory arthritis;
- Subjects with neuropathic conditions that have been painful or required therapy within the past 3 months;
- Subjects with evidence of significant structural abnormalities of the gastrointestinal (GI) tract or other significant conditions affecting GI motility;
- Subjects with chronic constipation not related to opioid use;
- Subjects who had surgical procedures directed towards the source of chronic low back pain within 6 months of the screening visit or planned during the study;
- Subjects with a history of malignancy within the past 2 years, with the exception of basal cell carcinoma that has been successfully treated.
- Other protocol specific inclusion/exclusion criteria may apply.
Exclusion
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
455 Patients enrolled
Trial Details
Trial ID
NCT01427270
Start Date
August 1 2011
End Date
October 1 2014
Last Update
November 7 2014
Active Locations (194)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigational Site
Alabaster, Alabama, United States, 35007
2
Investigational Site
Birmingham, Alabama, United States, 35242
3
Investigational Site
Gulf Shores, Alabama, United States, 36542
4
Investigational Site
Homewood, Alabama, United States, 35209